Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

NCT: NCT04368039 · TERMINATED

NCT IDNCT04368039
StatusTERMINATED
Start Date2019-12-04
Completion2026-10-13
SponsorNicholas Breitborde (OTHER)
First posted
Last updated

Brief Summary

Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑